These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 297011)

  • 1. [Sézary syndrome with terminal evolution in acute myeloblastic leukemia].
    Delsignore R; Quaini F; Rizzoli V; Baroni MC; Zavaroni G; Butturini U
    G Clin Med; 1979 Jul; 60(7):560-8. PubMed ID: 297011
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic evolution of 63 cases of recent acute myeloblastic leukemias].
    Fiere D; Bryon PA; Dechavanne M; Guyon JM; Kahi S; Revol L
    Lyon Med; 1971 Feb; 225(3):225-8. PubMed ID: 5280026
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complication of topoisomerase II inhibitor-related acute promyelocytic leukemia with t(1;10) (q21;q26) in a patient with Sézary syndrome].
    Miyoshi N; Noda M
    Rinsho Ketsueki; 2006 May; 47(5):399-401. PubMed ID: 16784098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular Sézary syndrome with bullous lesions on the feet.
    Dehesa L; Bastida J; Camacho-Galán R; Campos-Adsuar C; Gómez-Duaso J; Vilar-Alejo J
    Eur J Dermatol; 2009; 19(3):282-3. PubMed ID: 19258239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Leser-Trélat sign associated with Sézary syndrome and transitional cell carcinoma of the bladder].
    Martínez-Morán C; Sanz-Muñoz C; Miranda-Romero A
    Actas Dermosifiliogr; 2007 Apr; 98(3):214-5. PubMed ID: 17504710
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytologic modifications of acute myeloblastic leukemia and sympathicogonioma treated with Cerubidine].
    Dubois-Ferrière H; Schläpfer A; Bamatter F
    Schweiz Med Wochenschr; 1968 Oct; 98(42):1670-1. PubMed ID: 5246991
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.
    Bouwhuis SA; el-Azhary RA; McEvoy MT; Gibson LE; Habermann TM; Witzig TE; Pittelkow MR
    Int J Dermatol; 2002 Jun; 41(6):352-6. PubMed ID: 12100691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Sézary cryptogram. Disseminated cryptococcal infection.
    Desar IM; Stevens WB; Verweij PE; van der Velden WJ
    Neth J Med; 2011; 69(7):346, 349. PubMed ID: 21934182
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sézary syndrome with ascitis: case report and review of the literature].
    Nubourgh I; Van den Broeck K; Bradstreet C; Praet JP; Cantinieaux B
    Rev Med Brux; 2005; 26(5):445-50. PubMed ID: 16318098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bexarotene monotherapy for patients with refractory Sézary syndrome.
    Staib G; Scharffetter-Kochanek K
    Dermatol Clin; 2008 Jan; 26 Suppl 1():61-3. PubMed ID: 18405190
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunodeficiency and the pathogenesis of lymphoma and leukemia.
    Louie S; Schwartz RS
    Semin Hematol; 1978 Apr; 15(2):117-38. PubMed ID: 349695
    [No Abstract]   [Full Text] [Related]  

  • 12. Follicular hyperkeratosis as a manifestation of Sézary syndrome.
    Al-Niaimi F; Cox NH; Taylor WD
    Br J Dermatol; 2010 Mar; 162(3):695-6. PubMed ID: 20030643
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute leukemia in myeloma disease].
    Andreeva NE; Antipova LG; Arkavina EA
    Ter Arkh; 1981; 53(9):51-8. PubMed ID: 6946605
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myeloblastic leukemia following chemotherapy for mycosis fungoides.
    Waddell CC; Zubler MA; Gore WS
    Arch Dermatol; 1982 Mar; 118(3):179-82. PubMed ID: 6950688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-Sézary syndrome.
    Winkelmann RK; Buechner SA; Diaz-Perez JL
    J Am Acad Dermatol; 1984 Jun; 10(6):992-9. PubMed ID: 6234331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bexarotene combination therapy for patients with Sézary syndrome.
    Ranki A
    Dermatol Clin; 2008 Jan; 26 Suppl 1():55-7. PubMed ID: 18405189
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypoglycemia in a patient with advanced Sezary syndrome.
    Anagnostis P; Vakalopoulou S; Slavakis A; Simoulidou E; Rakitzi P; Garipidou V; Harsoulis F
    Leuk Lymphoma; 2009 Feb; 50(2):284-6. PubMed ID: 19160123
    [No Abstract]   [Full Text] [Related]  

  • 18. [Case of Lown-Ganong-Levine syndrome in a patient with myeloblastic leukemia].
    Dabrowski S; Kiersnowska-Rogowska B; Bodzenta A
    Pol Tyg Lek; 1982 Aug; 37(29-30):867-8. PubMed ID: 6961379
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemophagocytic syndrome induced by diaminodiphenylsulfone.
    Hiura Y; Kawabata H; Kanekura T; Terasaki K; Kanzaki T
    J Dermatol; 2007 Oct; 34(10):730-1. PubMed ID: 17908150
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of leukemia in children].
    Seip M
    Tidsskr Nor Laegeforen; 1974 Jan; 94(3):167-71. PubMed ID: 4522750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.